Skip to content

Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts

KRANIOPHARYNGEOM Registry 2019 Multicenter Registry for Patients With Childhood-onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04158284
Enrollment
90
Registered
2019-11-08
Start date
2019-10-01
Completion date
2024-06-30
Last updated
2024-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Craniopharyngioma, Obesity

Keywords

Quality of life, Endocrinology, Oncology, Hypothalamus, Irradiation, Neurosurgery, Pediatric Brain tumors

Brief summary

KRANIOPHARYNGEOM Registry 2019 will prospectively collect and descriptively analyse data on diagnostics, treatment, and follow-up of patients with craniopharyngioma. In continuation of preceding studies also patients with xanthogranuloma, meningioma, pituitary adenoma, prolactinoma and cystic intracranial malformations will be registered.

Interventions

None listed

Sponsors

German Society for Pediatric Oncology and Hematology GPOH gGmbH
CollaboratorOTHER
Deutsche Gesellschaft für Kinderendokrinologie und Diabetologie (DGKED)
CollaboratorUNKNOWN
Deutsche Gesellschaft für Endokrinologie (DGE)
CollaboratorUNKNOWN
Arbeitsgemeinschaft Pädiatrische Radioonkologie (APRO)
CollaboratorUNKNOWN
Deutschen Gesellschaft für Radioonkologie (DEGRO)
CollaboratorUNKNOWN
Klinikum Oldenburg gGmbH
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosed with craniopharyngioma for the first time 2. Age at diagnosis 18 years or less of age 3. Agreement from patient's parents or legal guardian as well as the patient

Exclusion criteria

1. Age at diagnosis over 18 years of age 2. Diagnosis different from craniopharyngioma

Design outcomes

Primary

MeasureTime frameDescription
Overall Survival3 years follow-upOverall survival as measured by Kaplan Meyer analyses
Progression-free Survival (PFS)3 years follow-upProgression-free survival as measured by Kaplan Meyer analyses

Secondary

MeasureTime frameDescription
Quality of life (QoL)3 years follow-upDomains of the PedQol instrument (questionnaire for assessment of health-related QoL in childhood cancer patients.

Countries

Germany

Contacts

Primary ContactHermann L Mueller, MD
mueller.hermann@klinikum-oldenburg.de+49 441 403
Backup ContactSvenja Boekhoff
boekhoff.svenja@klinikum-oldenburg.de+49 441 403

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026